Abstract Deficiency of IQGAP2, a scaffolding protein expressed primarily in liver leads to rearrangements of hepatic protein compartmentalization and altered regulation of enzyme functions predisposing development of hepatocellular carcinoma and diabetes. Employing a systems approach with proteomics, metabolomics and fluxes characterizations, we examined the effects of IQGAP2 deficient proteomic changes on cellular metabolism and the overall metabolic phenotype.
IQGAP2 also in white adipose, adrenal glands, pancreas and pancreatic islets (Wu et al. 2009 ); and IQGAP3 is reported to be present in brain, lung, testis, small intestine and colon (White et al. 2009; Schmidt 2012) .
IQGAP proteins have been implicated in cancer. IQ-GAP1 and several of its binding partners have been shown to promote metastasis and tumorigenesis causing IQGAP1 to be labeled as an oncogene (White et al. 2009 ). IQGAP2 on the other hand is a tumor suppressor (Schmidt et al. 2008; Xie et al. 2012) . IQGAP2 was originally shown in the regulation of thrombin-induced platelet cytoskeletal actin reorganization (Schmidt et al. 2003) . Later efforts showed that IQGAP2 exists in two pools; (i) as an integral component of a huge multi-protein scaffolding complex consisting of IQGAP1, IQGAP2, b-catenin and E-cadherin, and (ii) as part of the b-catenin destruction complex consisting of GSK3b kinase, axin and adenomatous polyposis coli (APC) (Schmidt et al. 2008) . Loss of IQGAP2 in SV129J mice led to an IQGAP1 dependent development of hepatocellular carcinoma (HCC) around 12 months of age (Schmidt et al. 2008 ). IQGAP2 has also been identified as one of the potential molecular targets of HCC in human liver biopsy samples (Lee et al. 2011) .
Scaffolding function of IQGAPs has been previously shown to involve the MAP kinase signaling pathway (Sacks 2006) . The participation of IQGAP2 in several pathways of mammalian cellular signaling, namely Wnt signaling, (GSK3b) and cAMP-PKA signaling (AKAPs) suggests the possibility that IQGAP2 might play a role in cellular energy homeostasis. This notion was supported by the observations (Chiariello et al. 2012 ) that IQGAP2 deficient murine models on a SV129J background displayed enhanced insulin sensitivity and were protected against high fat diet induced hepatic steatosis. Ca 2? /calmodulin signaling plays a well-known and crucial role in modulating insulin release by the pancreatic b-cells (Bratanova-Tochkova et al. 2002; Tomlinson et al. 1982; Valverde et al. 1979) . Interestingly the IQ motifs in IQGAP interact and bind calmodulin (Atcheson et al. 2011; Pathmanathan et al. 2011) . Further, IQGAP2 has been identified as a substrate for PKA phosphorylation and the binding partner for the AKAP220 forming a ternary complex together with PKA (Logue et al. 2011) . Recent findings by (Hinke et al. 2012) , highlight the importance of protein anchoring in insulin secretion and glucose homeostasis. We report here that whole body genetic ablation of Iqgap2 -/-on a C57BL/6J background presents with an obese, glucose intolerant and metabolically inflexible phenotype. Since cellular metabolic regulation is sensitive to alteration of scaffolding protein compartmentalization and alterations of changes in enzyme functions, we have employed a systems approach to examine proteomic and metabolomic changes in IQGAP2 deficiency. Since proteomic changes reflect adaptive mechanisms in metabolic networks, we were able to identify the systems-level metabolic changes associated with IQGAP2 deficiency by combining hepatic proteomics, metabolomics and metabolic flux measurements.
Our principal findings include (a) parallel accelerations of both glycolysis and gluconeogenesis inducing futile hepatic carbon cycling, (b) augmented malate-aspartate shuttle (anaplerosis), and (c) enhanced de novo lipogenesis. These metabolic derangements together with IQGAP2 scaffolding function in intracellular signaling, implicate IQGAP2 as more than just a casual participant in the modulation of cellular homeostasis. Our results suggest that changes in metabolic networks resulting from IQGAP2 deficiency create a hepatic environment congenial for neoplastic transformation.
Materials and methods

Ethics statement
All animal studies were performed under approved institutional protocols and according to guidelines established in the Guide for the Care and Use of Laboratory Animals.
Animals
Iqgap2
-/-mice on a C57BL/6J background were a generous gift from Dr. Schmidt VA (SUNY, Stony Brook). Age matched C57BL/6J obtained from The Jackson Laboratory (Bar Harbor, Maine, USA) were used as controls. All animals were males, 4-5 months of age, and fed standard laboratory chow diet (PICOLab Rodent Diet 20; 5058) . Animals were maintained under 12-h light/dark conditions (0700 h/1900 h) for all studies. Animals from each group for calorimetry experiments (n = 4) were also used for body composition analyses (n = 5) and stable isotope glucose tolerance test (n = 10) and were finally sacrificed after [U- 13 C 6 ]-glucose infusions using Alzet osmotic mini-pump experiments.
Body composition
Body composition was determined by low resolution NMR. Percent lean mass and fat mass were calculated as a proportion of body weight. Iqgap2 -/-mice and age matched control mice were examined.
Indirect calorimetry
Measurements of oxygen consumption (VO 2 ) and respiratory quotient (RER) were performed using an Oxymax indirect calorimetry system (Columbus Instruments, IQGAP2 in metabolic homeostasis 921
Columbus, OH). Mice (n = 8) were housed individually in the chamber for 48 h with lights on from 0700 to1900 h in an ambient temperature of 22-24°C. Food and water was available adlib. Gas exchange measurements were made under Oxymax system settings as follows: air flow, 0.6 l/ min; sample flow, 0.5 l/min; settling time, 6 min; and measuring time, 3 min. Ambulatory activity was determined simultaneously using an Opto-Varimetrix-3 sensor system. Consecutive adjacent infrared beam breaks in either the x-or y-axes were scored as an activity count.
Fast/refed studies
In order to evaluate metabolic flexibility, proteomic and metabolomic samples were collected from animals according to the fast/refed paradigm. Animals had access to food and were allowed to eat for an hour and half after the beginning of the dark cycle (1900 h). Fasting was initiated by removing the food at 2030 h. Animals (n = 5) for each group (Iqgap2 -/-and control) were sacrificed the next day either at the end of 18 h fast (1430 h) or refed for 5 h (13 h over-night fast and refed for 5 h beginning 0930-1430 h). Liver and skeletal muscle (whole quadriceps) were harvested, snap-frozen in liquid N 2 and stored at -80°C until further analysis. Livers from the fast and refed experiments performed without tracer were used for hepatic metabolite profiling, immunoblot, glycogen, lipid TLC, acetyl CoA, and proteome (n = 3) analyses. Short term fast studies were done for estimating glycogenolysis and de novo lipogenesis. For analyses of glycogen (liver and muscle), and de novo lipogenesis fast was initiated by removing food at the beginning of the light cycle (0700 h) for 4 h (1100 h). At the end of 4 h fast, 3 groups of 5 animals were sacrificed after an additional 30, 60, and 150 min. Plasma, liver and skeletal muscle (whole quadriceps) were harvested snap-frozen in liquid N 2 and stored at -80°C until further analysis.
Stable isotope flux phenotyping (SIPHEN)
SIPHEN studies included [U-13 C 6 ]-glucose infusions delivered using Alzet mini-osmotic pumps to determine glucose turnover (Xu et al. 2002) and glucose re-cycling and (SipGTT) stable isotope labeled glucose tolerance test ([6,6-2 H 2 ]-glucose) to evaluate insulin sensitivity (Xu et al. 2003) . All stable isotopes were purchased from Cambridge Isotope Laboratories (Andover, MA, USA.) and were pyrogen tested before use. Blood samples were analyzed on a GC/MS after compound isolation and derivatization. For details see our previous studies (Xu et al. 2002 (Xu et al. , 2003 Vaitheesvaran et al. 2010b) . Lipogenesis was measured using deuterated water [ 2 H 2 O], tracing the enrichment of deuterium in stearate and cholesterol (Lee et al. 1994 ).
Mice were fasted at 0700 h for 4 h. At 1100 h, mice received an intraperitoneal injection of deuterated water ( 2 H 2 O, at a concentration of 4 % lean body mass) containing 0.9 % sodium chloride and were maintained on 4 % 2 H 2 O as drinking water till the end of the experiment. Mice were sacrificed at the end of each time point (30, 60 and 150 min) following the 4 h fast (0700-1100 h). Blood was collected from the retro-orbital sinus. Liver and skeletal muscles (quadriceps) were removed and snap frozen in liquid nitrogen. Plasma was used for measuring body deuterium enrichment. Fatty acids were analyzed as its trimethylsilyl derivative using gas chromatography (GC)-electron impact ionization mass spectrometry (MS) as previously described (Brunengraber et al. 2003) .
Hepatic metabolite profiling
Metabolite measurements for fast/refed Iqgap2 -/-mice and control mice liver samples were performed using freeze clamped liver samples from fasted/refed experiments that were extracted in ice-cold methanol/water (1:1) spiked with internal standards (U-13C4 succinate and U-13C6 citric acid, (150 nm/g liver). The aqueous phase was lyophilized, derivatized as previously described (Roessner et al. 2000) , GC-MS analysis performed using an Agilent 7890a GC with a Gerstel automatic liner exchange cooled injection system CIS 4 PTV injector. Both split and large volume injections (LVI) of the sample were made. GC-MS conditions and metabolite identification was done as described (Kind et al. 2009 ) and metabolites were identified using using NIST 11 and Fiehn mass spectral libraries.
For hepatic mass isotopomer analysis freeze clamped liver samples from [U-13 C 6 ]-glucose infusion experiments was extracted in ice-cold methanol. Extracts were lyophilized and analysed on GCMS as trimethyl silyl esters under chemical ionization conditions with 20 % methane as reagent gas under GC oven conditions as described in (Kind et al. 2009 ). Selective ion monitoring of (m/z 218 for alanine, m/z350 for aspartate, m/z348 for glutamate) and their respective isotopomers (m ? n) ions were monitored.
LCMS analysis was performed in a Waters Acquity UPLC system attached to a Xevo Triple Quadrupole mass spectrometer equipped with an electrospray ionization source (ESI) (Waters Corp., Milford, MA) for acylcarnitines in plasma (Ghoshal et al. 2005 ) and hepatic acetyl CoA (Gilibili et al. 2011) with slight modifications for sample preparation as described in Supplemental Notes.
A detailed description for any modifications and metabolites measurements using GCMS analysis is described in Supplemental Notes.
Thin layer chromatography, glycogen and immunoblot analysis
Lipid content analysis using thin layer chromatography (TLC), glycogen content, and immunoblotting were performed as described previously (Vaitheesvaran et al. 2012; Vaitheesvaran et al. 2010a ). Detailed procedure is described in the Supplemental Notes.
Serum analysis
Plasma glucose levels were determined by COBAS MIRA analyzer (Roche, Montclair, NJ) using the Glucose UV Reagent (catalog no. 80017, Raichem, San Diego, CA, USA.). Plasma insulin was determined using an ultra-sensitive rat/mouse Insulin ELISA Kit (Crystal Chem. Inc., Cat# 90060, USA.).
Statistical analyses
Data are expressed as the mean ± SEM. Analyses for the significance of differences were performed using the Student's t test and Anova using GraphPad Prism version 5.00 for Windows, GraphPad Software, San Diego California USA, www.graphpad.com.
3 Quantitative proteomic analysis by liquid chromatography-mass spectrometry (LC-MS)
Protein digestion and desalting
Liver proteins from fast/refed animals were extracted in ice-cold RIPA buffer containing suitable protease and phosphatase inhibitors (Roche diagnostic cocktail tablets, Indianapolis, USA). Proteins were precipitated with acetone, followed by centrifugation at 22,000g for 10 min. were loaded on a pre-conditioned C18 column and subsequently washed/desalted three times using deionized water with 0.1 % TFA. In the final concentration step, the peptides were eluted in 250 lL of 70 % acetonitrile:0.1 % TFA and then dried by vacuum centrifugation. The digests were reconstituted in 50 lL of 0.1 % formic acid in water and peptide concentrations were determined by BCA assay (Pierce, Rockford, IL, USA.). These stock digests were stored at -80°C until use. The stock digests were thawed and a 500 lg/mL of working solution of peptide digests were prepared in solvent A (water containing 0.1 % formic acid), prior to the LC-MS analysis.
LC-MS analysis
The peptide samples (500 lg/mL) were analyzed in triplicate using a nanoAcquity UPLC (Waters, Milford, MA) coupled to a custom Velos-FTICR Ultra hybrid mass spectrometer (Weisbrod et al. 2013 (Park et al. 2008) , for calculating spectral counts for the identified proteins from each sample by Normalized Spectral Index (SI N ) method (Griffin et al. 2010) . A PeptideProphet (Keller et al. 2002) -/-mice samples), and one-way analysis of variance (ANOVA) test was performed to identify changes in protein levels between the two conditions that appeared statistically significant. A nominal P value cut off of 0.05 was used to compute a list of significantly changing proteins between control versus Iqgap2 -/-mice.
Results
Iqgap2
-/-mice were generally obese and hyperglycemic. General body composition, plasma glucose and insulin measurements for Iqgap2 -/-and control mice following an overnight fast are given in Supplemental Table S1 . Food intake was similar between both groups of mice. Iqgap2 -/-mice were heavier and showed a significantly altered body composition compared to control mice. Iqgap2 -/-mice had [8 times body fat mass percentage and significantly lower lean body mass (P \ 0.001) than the control mice. These changes readily suggest alterations in fuel substrate metabolism which were investigated further using indirect calorimetry, metabolomics and proteomics.
Metabolic inflexibility in Iqgap2
-/-mice: indirect calorimetry analyses Figure 1 shows indirect calorimetric measurements on Iqgap2 -/-and control mice made during three different nutritional challenges namely adlib, overnight fast for 12 h and refed for 5 h. During the adlib feeding period, RER (respiratory exchange ratio) for Iqgap2 -/-mice were consistently lower than those of the control (\0.9 vs.
[0.90, P \ 0.05). During an overnight fast, RER of both Iqgap2 -/-and control mice were similar at about 0.75 suggesting fatty acids being the major fuel. Upon, refeeding, RER for the control mice approached 1.0 and about 0.90 for the Iqgap2 -/-mice. Oxygen consumption (VO 2 ) normalized to total body mass, to lean body mass and ambulatory activity were all observed to be comparable between the groups (Supplemental Figure S1 ). RER measurements represent fuel utilization by the skeletal muscle. Therefore, lower RER despite comparable oxygen consumption with IQGAP2 deficiency implies a substrate preference toward amino acid and fatty acid oxidation by the skeletal muscle of Iqgap2 -/-mice as compared to the control mice in the fed state.
Plasma amino acid profile for Iqgap2 -/-and control mice during overnight fast/refed experiments are shown in Supplemental Table S2 . Amino acids constitute a significant segment of fuel substrates and their levels fluctuate between fast and refed states. The fast/refed ratio indicates the periods when the plasma amino acids are most consumed or replenished. Ratios less 1 than indicates that the amino acid is replenished by refeeding and ratios greater than 1 indicates that the amino acid is better used during the fed period. For example, fast/refed ratios of the two gluconeogenic amino acids alanine and glutamic acid, were below one for both Iqgap2 -/-and control mice, indicating that these amino acids were replenished after refeeding. Metabolic inflexibility is expected to affect utilization of amino acids. Results in Table S2 demonstrate not only that fasting amino acid profiles were different between Iqgap2 -/-and control mice (last column of Table S2 ), but the dynamic changes within and between fast/refed two conditions was also different. Notably, Iqgap2
-/-mice synthesized and consumed the branched chain amino acids (BCAA) valine, leucine differently (also see Supplemental Figure S2 ). Iqgap2
-/-mice also demonstrated abnormality in plasma profiles of serine, threonine and glycine, the amino acids involved in one-carbon metabolism. Serine and glycine are products of glucose and precursors for gluconeogenesis. The serine-glycine pathway is energy producing and a source of substrates for nucleotide base -/-and control mice were determined during the diurnal cycle and fasted to refed transitions. Day (light cycle) and night (dark cycle) 12 h, (over)night fast-15 h, day refed-5 h in duration. n = 8, data are mean ± SEM. Error bars are represented only in one direction for clarity synthesis and methyl donor generation. It can be seen from Table S2 that in the fasted Iqgap2 -/-mice, levels of serine were increased over two-fold (fast/refed: 2.28, P \ 0.05; Fast Iqgap2 -/-/control: 2.24, P \ 0.05) while glycine levels were decreased by *20 to 25 % in both comparisons. Observations of increased levels of 3-phosphoglycerate (see below), a glycolytic and also an intermediate of serine biosynthetic pathway during the 18 h fast reflects the altered plasma profile of serine and glycine in fasted Iqgap2 -/-mice.
Abnormal central glucose metabolism in Iqgap2
-/-mice Glycolytic intermediates as expected were generally higher for control mice after refeeding compared to those of the fasted state (Fig. 2) . But the glycolytic intermediates of
Iqgap2
-/-mice in the fasted state were in the same order of magnitude as those after refeeding and were statistically higher than those of the fasted control mice (Fig. 2a, c) . It is important to note that glycolytic intermediates are also intermediates of the pentose cycle. Consequently, pentose cycle intermediates were also elevated (discussed below) in Iqgap2 -/-mice during the 18 h fast. Metabolic intermediates of the TCA cycle did not fluctuate between fasting and refeeding between the groups; while citrate and isocitrate were significantly increased in Iqgap2 -/-mice during the18 h fast (Fig. 2b, d) . Figure 3 illustrates glucose, glycogen and insulin measurements from Iqgap2 -/-mice compared to control mice. The observed elevation of glycolytic intermediates in Iqgap2 -/-mice could be the result of increase glycolytic flux or metabolic compensation for ineffective glycolysis. If glycolytic flux were responsible, one would also expect to observe rapid disappearance of plasma glucose and hepatic glycogen. However during a short-term fast, the decrease in blood glucose (Fig. 3a) and liver glycogen (Fig. 3b) in Iqgap2 -/-mice appears much slower than those in control mice. This suggests impaired glycogenolysis and ineffective glycolysis as compared to pentose cycle metabolism with IQGAP2 deficiency. Associated with changes in glycolytic and pentose cycle pathways was the development of hyperglycemia (Fig. 3c) and hyperinsulinemia ( Fig. 3d) in the Iqgap2 -/-mice compared to the control.
-/-mice were both hyperinsulinemic and hyperglycemic demonstrating 38 % higher plasma glucose, despite a 3-fold increase in plasma insulin (also Table S1 ). Figure 3e illustrates mass isotopomers during stable isotope [U-13 C 6 ]-glucose (M ? 6) infusion studies to evaluate hepatic glucose production. Mi/ P m is the mass isotopomers from infusion and recycling of [U-13 C 6 ]-glucose (M ? 6) with i number 13 C substitutions as a fraction of the total labeled molecules
The fraction of M ? 6/ P m was lower for Iqgap2 -/-mice. However, hepatic glucose production (Supplemental Figure S3a , 19.5 ± 1.6 mg/kg/min for Iqgap2 -/-mice, 20.4 ± 2.5 mg/kg/min for the control mice) was comparable between the groups. Liver produces glucose (hepatic glucose production) during the fasted state by gluconeogenesis and glycogenolysis. [U-13 C 6 ]-glucose molecules can also be taken up and metabolized in the muscle to lactate and alanine producing m ? 3 lactate and alanine. These labeled metabolites are subsequently recycled into glucose in the liver (gluconeogenesis). Since the probability of two labeled lactate species coming together is low, the new glucose is labeled as m ? 1, m ? 2 and m ? 3. Gluconeogenesis from lactate consumes energy. The process of glucose becoming lactate and then glucose again is known as the Cori cycle and is a futile process where energy is expended to complete the cycle (Lee et al. 1991) . As was seen earlier from Fig. 3b , glycogenolysis was impaired in Iqgap2 -/-mice. The fraction of infused [U-13 C 6 ]-glucose molecules that recycled as M1/ P m, M2/ P m, M3/ P m was significantly higher for Iqgap2 -/-mice (Fig. 3e) . The sum of mass isotopomers (M1/ P m ? M2/ P m ? M3/ P m) represented as 'F' which is the fraction of molecules contributed by Cori cycling and is also the percent contribution to hepatic glucose production from Cori cycling (Lee et al. 1992) , was significantly higher in Iqgap2 -/-mice (58.0 ± 3.4 %) compared to control mice (49.5 ± 2.7 %, P \ 0.002) (Supplemental Figure S3b ). These results demonstrate that despite impaired glycogenolysis, increased glucose carbon recycling through gluconeogenesis (Cori cycle) maintains the hepatic glucose production in Iqgap2 -/-mice, which is a factor contributing to hyperglycemia observed with IQGAP2 deficiency.
Peripheral glucose utilization in Iqgap2 -/-mice was further evaluated by a stable isotope glucose tolerance test (SiGTT) using [6,6-2 H 2 ]-glucose. Peripheral glucose utilization was calculated as the rate of disappearance of stable isotope labeled [6,6-2 H 2 ]-glucose and was significantly slower for the Iqgap2 -/-mice as indicated by the increased levels of D 2 -glucose observed in mutant mice at 30 min (Fig. 3f) -/-mice for the development of Type II diabetes (Vaitheesvaran et al. 2012 ).
Anaplerosis (truncated TCA cycle) and fatty acid metabolism
Effects of anaplerosis (truncated TCA cycle) on lipid homeostasis in Iqgap2 -/-mice are illustrated in Fig. 4 . Metabolites pertaining to fatty acid synthesis and oxidation are represented as left and right panels respectively. Mitochondrial function is characterized by a balance between anaplerosis, oxidation and use as precursors, two critical processes that control the entry and exit of metabolites into the TCA cycle (Owen et al. 2002) . Increased anaplerosis implies truncated TCA cycle which is a mechanism for gluconeogenesis, malate shuttle and citrate cycle. These processes regenerate gluconeogenic amino acids, acetyl-CoA and reducing equivalents. Increased anaplerosis with IQGAP2 deficiency was also evident from hepatic mass isotopomer distributions of aspartate and glutamate analysed by [U-13 C 6 ]-glucose infusion experiments (Supplemental Table S6 ). During anaplerosis, substrate flux of the individual TCA cycle intermediates exceeds that of the TCA cycle flux in support of gluconeogenesis, amino acid synthesis and nucleic base synthesis. Functionally it operates as if TCA cycle is truncated. These metabolic changes were clearly evident with IQGAP2 deficiency and are illustrated by the different panels in the Fig. 4 . An increased level of pentose intermediates indicative of increased pentose cycle activity provides reducing equivalents (NADPH) for the increased de novo lipogenesis. Accordingly it can be noted that the increase in hepatic pentose intermediates during the 18 h fast in Iqgap2 -/-mice ( Fig. 4a) was associated with increased hepatic acetyl-CoA concentration (Fig. 4b) and an increase in hepatic de novo lipogenesis (Fig. 4c) . In inborn errors of metabolism wherein oxidation of fatty acids or branch chain amino acids are compromised, plasma short chain (C2,C3,C4) acylcarnitine levels are increased reflecting increased intracellular acylcarnitine pool. Figure 4d illustrates plasma acylcarnitine profile in Iqgap2 -/-and control mice during a short term fast. It can be noted that acylcarnitine levels of medium and long chain fatty acids (C6-C16) were significantly decreased, whilst short chain (C2, C3, C4) had a tendency to increase in Iqgap2 -/-mice compared to those of control suggesting increased fatty acid b oxidation. The decreased plasma acylcarnitine in Iqgap2 -/-mice was associated with elevated free fatty acid levels both in the fast (Fig. 4e) and fed (Fig. 4f) states. Despite signs of elevated fatty acid oxidation, plasma b-hydroxybutyrate levels were lower in the Iqgap2 -/-mice compared to the control (0.55 ± 0.05 vs. 0.87 ± 0.06 lg/lL, P \ 0.01). Plasma cholesterol was IQGAP2 in metabolic homeostasis 927 increased both during 18 h fast and refeeding in Iqgap2
-/-mice. Acetoacetate is the common substrate for the ketone body, cholesterol and fatty acid synthesis and can be reduced to b-hydroxybutyrate depending on the NAD pool of the cell. Decreased plasma b-hydroxybutyrate levels in Iqgap2 -/-mice reflect abnormal regulation of ketone body mean ± SEM for fatty acid deuterium enrichment, n = 5. *P \ 0.05, **P \ 0.01 for Iqgap2 -/-vs. control mice. d Plasma acylcarnitine profile at (150 min) at the end of a short-term fast experiment. e Plasma lipid metabolites during 18 h fast, f plasma lipid metabolites during 5 h re-feeding experiment. All plotted data points indicate the mean value ± SEM, n = 5, *P \ 0.05, **P \ 0.01, ***P \ 0.001 for Iqgap2
-/-vs. control mice synthesis in light of the suspected increased fatty acid oxidation. A 6-fold increase in HMG-CoA synthase, enzyme involved in cholesterol biosynthetic pathway reflects the above observation (Table 1 ).
Proteomics metabolomics correlation
Since IQGAP2 is primarily expressed in the liver, we profiled the hepatic proteome and metabolome to examine phenotypic changes of IQGAP2 deficiency. Accordingly hepatic proteome and metabolome analyses were done on 1iver tissues from 18 h fast/refed Iqgap2 -/-and control mice. Table 1 shows a list of metabolic proteins critical to major biochemical pathways distributed in the cytosol and mitochondria showing C2.5-fold differential expression that helped to explain the Iqgap2 -/-phenotype. A complete list of identified proteins with statistically significant differential abundance levels (P \ 0.05) is given in the Supplemental Table S3 . Critical proteins were validated by immunoblots (Supplemental Figure S4a) and quantified (Supplemental Figure S4b) . A total of 176 proteins showed statistically significant (P \ 0.05) altered levels with 91, 48, and 72 proteins showing ± 2.5-fold changed levels in the fasted Iqgap2 -/-compared to the fasted control, refed
Iqgap2
-/-compared to refed control, and in the fasted Iqgap2 -/-compared to the refed Iqgap2 -/-, respectively (Supplemental Table S3a ). Several of these proteins include known IQGAP-related proteins involved in cytoskeleton, motility and proliferation. Proteins with critical enzyme functions regulating major metabolic pathways governing fuel homeostasis, including glycolysis, gluconogenesis, lipogenesis and cellular stress response pathways mostly showed increased levels. Nuclear proteins, RNA binding proteins, calcium binding proteins and major urinary proteins all showed decreased levels. Pathways were enriched using Benjamini-Hochberg corrected P value cut off of B 0.05 for significance. A cytoscape image for the KEGG pathways of all statistically significant proteins (±2.5-fold change) in the fasted and refed comparisons were colored according to overlapping terms (proteins shared by related KEGG groups) and node size based on adjusted P value for enrichment (Bindea et al. 2009 ), is summarized in Fig. 5 and the list of proteins that map to each node is given as Supplemental Table S3b . The combination of differential protein levels given with respective metabolic intermediate levels and flux can help explain the IQGAP2 deficient metabolic compensations to maintain cellular homeostasis as follows. A list of critical metabolic proteins which showed significant (P value B 0.05) fold changes (FC) in Iqgap2 -/-mice (fast or refed) as compared to their respective age-matched control mice (fast or refed), as calculated by the Spectral Indexing (SI N ) methods of quantitation. Two proteins (Q8QZR5 & Q91W43) with Uniprot accession number marked with ** showed more than 6-fold change and were retained in the analysis despite of being detected in fewer than 6 LC-MS/MS runs per sample 4.3.1 Proteome of impaired glucose homeostasis IQGAP2 deficiency results in increased glycolytic intermediates (Fig. 2) and amino acids (Supplemental Figure  S2 ) during 18 h fast. As seen from Table 1 , glycolytic enzymes that were elevated in the fasted Iqgap2 -/-compared to the fasted control include fructose-bisphosphate aldolase B (2.6-fold increase), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (2.6-fold increase), (R/L) pyruvate kinase (PK) (4.9-fold increase). Since the plasma levels of serine and glycine (gluconeogenic amino acids) from Iqgap2 -/-mice exhibited changes in the opposite directions as discussed before with the 2-fold increased levels of serine (Supplemental Figure S2) , we anticipated an increase in the levels of serine hydroxymethyltransferase (Shmt1) which is involved in the synthesis of serine from glycine. Our proteomics data identified[5 peptides of Shmt1 and showed an increase of 1.6-fold (nominal P value = 0.16) by spectral counting method in the fasted Iqgap2 -/-mice as compared to their fasted controls (Supplemental Table S4 ). Peptide level MS 1 intensity quantitation using the 5 identified peptides of Shmt1 showed an average increase of *2.8-fold with nominal P values ranging from \0.05 to [0.15. Although the P values ([0.05) corresponding to these fold changes were high, the observed increase in Shmt1 enzyme is consistent with the changes in serine and glycine levels. Also mitochondrial citrate lyase subunit beta-like protein (3.3-fold increase) was elevated during 18 h fast in Iqgap2 -/-livers. Such proteomic changes were also directly corroborated by metabolites changes respectively in Iqgap2 -/-livers. For example increased level of aldolase B was reflected by increase in DHAP levels, and pyruvate kinase by pyruvate levels. Concentrations of glycolytic intermediates are affected by glucose influx and efflux. Glucose influx into the glucose-6-phosphate pool includes glucose uptake and phosphorylation, gluconeogenesis and glycogenolysis. Glucose efflux includes glycogen synthesis, pentose cycle and TCA cycle. The initial step for pyruvate to enter the TCA cycle is through pyruvate dehydrogenase action. Mitochondrial pyruvate dehydrogenase protein X component (PDH) regulates pyruvate oxidation to acetyl CoA (glucose oxidation and fatty acid synthesis); while pyruvate carboxylase (PC) regulates anaplerosis (gluconeogenesis) respectively. Both the enzymes were identified to be simultaneously increased (4.5-fold increase for PC and 3.6-fold increase for PDH) only in fasted Iqgap2 -/-mice but not in control mice (see Supplemental Notes for detailed description). The observed increase in levels of the mitochondrial citrate lyase subunit beta-like protein in Iqgap2 -/-livers may be important for cleaving citrate to oxaloacetate and acetyl CoA in Iqgap2 -/-livers. Hepatic metabolite measurements indicating significant increases in intermediates common for glycolysis and gluconeogenesis such as fructose-6-phosphate and 3 phospho glycerate, PEP, pyruvate, citrate (Fig. 2 ) and acetyl CoA (Fig. 4b) in Iqgap2 -/-liver during the 18 h fast corroborates the proteomic observations. The results are also supportive of increased glucose carbon recycling and illustrate the aberrant regulation of glucose metabolism in Iqgap2 -/-livers. It is possible that in Iqgap2 -/-livers, increased acetyl CoA (Fig. 4b) can be transported to cytosol via the acetoacetate shuttle leading to increased de novo lipogenesis (Fig. 4c) that impaired lipid homeostasis in Iqgap2 -/-mice as discussed below.
Proteome of altered lipid homeostasis
Several critical proteins pertaining to lipid metabolism showed increased levels ( Table 1) . Aldolase B, lysosomal ganglioside GM2 activator (GM2AP) and peroxisomal alpha methyl acyl CoA racemase (AMACR) were increased in 18 h fasted Iqgap2 -/-mice compared to fasted control. Apolipoprotein A-II (apoA-II) was increased in refed Iqgap2 -/-mice compared to refed control. AMACR, and HMG-CoA synthase were increased in 18 h fasted Iqgap2 -/-mice compared to fasted control mice. Also, immunoblots (Supplemental Figure S5 ) confirmed increased levels of major enzymes [acetyl CoA carboxylase (ACC), fatty acid synthase (FAS), ATP citrate lyase, DGAT1] involved in lipogenesis suggesting aberrant channeling of glycolytic flux to an increased lipid synthesis. TLC for lipids (Supplemental Figure S6 ) confirmed accumulation of triglycerides in Iqgap2 -/-livers both during fast and refed states. Increased lipogenic precursor metabolites dihydroxyacetone-P (DHAP), a-glycero-P (Fig. 2) , pentose intermediates and acetyl CoA (Fig. 4) that are critical for de novo lipogenesis and triglyceride synthesis support our proteome observation. Changes in proteins pertaining to peroxisomal function were also observed. The 3-fold increase in peroxisomal b-oxidative AMACR observed in Iqgap2 -/-compared to control mice might be associated with increased oxidation of branched chain fatty acids in these mice, the products of which have carcinogenic potential (Lloyd et al. 2008) . Lysosomal GM2AP is an adipokine that binds and transports a broad spectrum of lipids including phosphatidylcholine; serum levels of GM2AP is found to be increased in obese mice, human and is implicated with hepatic and pancreatic dysfunction through impairment of insulin signaling (Higashi et al. 2011) . Given Iqgap2 -/-mice are obese, the observed increase GM2AP suggests altered phospholipid metabolism with IQGAP2 deficiency. A 6-fold increase in HMG-CoA synthase which catalyses the formation HMG-CoA, a critical substrate in cholesterol biosynthesis reflects abnormal regulation of cholesterogenesis in Iqgap2 -/-livers.
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Proteome of urea/TCA cycle metabolism
Urea is the principal end-product of protein metabolism in mammals. Urea cycle is inextricably intertwined to TCA cycle and spans both mitochondrial and cytosolic compartments. Mitochondrial carbamoyl-phosphate synthase catalyzing the first committed step in urea synthesis was increased (2.7-fold) in Iqgap2 -/-mice during the refed state. Cytosolic arginosuccinase, the enzyme catalyzing the third step of the urea cycle cleaving arginosuccinate to fumarate and arginine indicated a 3.1-fold increase during 18 h fast in Iqgap2 -/-mice. Fumarate and aspartate link urea cycle and TCA cycle through transamination of oxaloacetate (OAA) an important gluconeogenic precursor and TCA intermediate. Interestingly, the respective enzymes fumarase (4.7-fold increase), and mitochondrial aspartate aminotransferase (mAspAT) (2.9-fold increase) both showed altered levels during 18 h fast in Iqgap2 -/-livers. Glycine N-methyltransferase is found predominantly in periportal cells which is the major site of gluconeogenesis, methyl-donor formation and urea biosynthesis (Ogawa et al. 1998) . Glycine N-methyltransferase, also showed 2.7-fold increase with IQGAP2 deficiency during 18 h fast. Increased levels of glycine N-methyltransferase and urea cycle enzymes indicate active metabolism in Iqgap2 -/-livers to effectively remove ammonia resulting from increased gluconeogenesis. Also, alanine amino transaminase (ALT) which catalyzes the reversible transamination of alanine to pyruvate demonstrated a 6.6-fold increase during the 18 h fast with IQGAP2 deficiency. Increase of ALT was reflected by decreased hepatic alanine levels (Supplemental Table S5 ) and concomitantly increased hepatic pyruvate (Fig. 2) levels. Thus these results strongly corroborated and support increased gluconeogenesis from amino acids with IQGAP2 deficiency.
Proteome of impaired hepatocellular energetics
As seen from Table 1 (i) Critical cytosolic dehydrogenases [GAPDH, malate dehydrogenase (MDH) and alchohol dehydrogenase (ADH)], (ii) redox proteins (glutaredoxin-1, glutathione-S-transferease and peroxiredoxin-5, thiredoxin reductase), (iii) proteins associated with malate-aspartate shutte (MAS) namely the inner mitochondrial translocase protein TIM13, mitochondrial aspartate aminotransferase, fumarate hydratase, (iv) proteins associated with mitochondrial ATP production namely mitochondrial adenylate kinase 2, (AK2) and ATP synthase subunit a (complex V) were found to be increased during the 18 h fast in Iqgap2 -/-mice. Interestingly AMP was also found to be increased in Iqgap2 -/-mice compared to controls (Fig. 2a) . Electron carrier proteins from electron transport chain [(cytochromes b5, C-III) and electron transfer flavoprotein] were found to be increased during the refed state in Iqgap2 -/-livers compared to the refed control. Antioxidant metabolites (Supplemental Figure S7) hypotaurine, ascorbic acid and glutathione were decreased in Iqgap2
-/-mice demonstrated a threefold increase in TIM13 the inner mitochondrial translocase protein which regulates the mitochondrial aspartate/glutamate carriers (AGC) (Roesch et al. 2004) ; AGC plays key role in transferring the cytosolic NADH to mitochondrial matrix. Mitochondrial malate-aspartate shuttle, a primary cytoplasmic NADH electron shuttle (Barron et al. 1998) , is activated by high cytosolic NADH. Thus observed hepatic increases of critical cytosolic dehydrogenases and increases in proteins linked to the malate-aspartate shuttle suggests augmentation of the shuttle and are signs of compromised redox equilibrium between cytosol and mitochondria in Iqgap2 -/-mice.
Discussion
Signaling pathways and metabolic pathways constitute the cellular metabolic network. They work by the rule of balance of flux (Ma et al. 2012) . A balance between phosphorylation and dephosphorylation of signaling molecules, and between metabolite turnover is required to maintain cellular homeostasis. We present evidence that signaling pathways and metabolic pathways are highly integrated, by demonstrating that interruption of protein scaffolding in the Iqgap2 -/-mice has significant impact on the metabolic network as reflected by the proteomic and metabolomic changes in the cytosolic and mitochondrial compartments. The scaffolding and tumor-suppressor protein IQGAP2 primarily expressed in liver is a PKA substrate and binds AKAP220, the featured anchoring protein in protein kinase A and GSK3b signaling. Proteomics changes corroborated by the observed metabolomic and flux changes in our study, demonstrated profound alterations in hepatic intermediary metabolism with IQGAP2 deficiency. Our integrative approach, lets us infer that IQGAP2 deficiency results in loss of reciprocal regulation of glycolysis/gluconeogenesis, metabolic inflexibility, and obesity which are common etiological factors for predisposition to diabetes and hepatocelluar carcinoma. Since phosphorylation of the bi-functional enzyme (6-phosphofructo-2-kinase/ fructose 2,6-bisphosphatase [FK2/FBP2]) by PKA triggers the major switch between glycolysis and gluconeogenesis (Pilkis and Granner 1992) , erroneous hepatic regulations of PKA signaling regulated metabolic pathways (Lu and Shyy 2006; Duncan et al. 2007 ) in Iqgap2 -/-mice implicates a putative role for IQGAP2 in cAMP-PKA signaling.
IQGAP2 deficiency and diabetes
Insulin resistance, lipid accumulation, mitochondrial dysfunction and metabolic inflexibility have been implicated in the etiology of type 2 diabetes (van de Weijer et al. 2013) . Increased hepatic glucose cycling has been associated with hyperglycemia (Vranic 1992 ) chronic persistence of which disrupts insulin-stimulated glucose utilization leading to insulin resistance (Reaven et al. 1989 -/-livers. It has been shown that formation of acetoacetate in the mitochondria and its utilization in the cytosol is a secondary pathway of acetyl group translocation operating concurrently with the predominant citrate cleavage pathway (Endemann et al. 1982 ) and mitochondrial acetyl-CoA contributes about 36 % to de novo lipogenesis (Goldberg and Brunengraber 1980) . Since plasma levels of b-OH butyrate in Iqgap2 -/-mice were decreased despite increased fatty acid oxidation, one hypothesis is that excess mitochondrial acetyl CoA formed in Iqgap2 -/-liver fueled mitochondrial steroid synthesis or got shuttled to cytosol (acetoacetate shuttle/carnitine shuttle) to fuel de novo cholesterol and fatty acid synthesis.
Since we observed that glycogenolysis was impaired in Iqgap2 -/-mice, consequential use of glucogenic amino acids to feed pyruvate (gluconeogenesis), and lipid synthesis accelerates protein turnover, resulting in increased lipid accumulation and obesity. Both proteomic and IQGAP2 in metabolic homeostasis 933 metabolomic results in our study confirms abnormal regulation of lipid homeostasis in Iqgap2 -/-mice. We found critical enzymes from lipid metabolism, lipogenic metabolites like a-glycero phosphate, acetyl CoA and pentose intermediates all to be significantly increased in Iqgap2 -/-livers. We also demonstrated that de novo lipogenesis was increased with IQGAP2 deficiency. TLC results confirmed increased accumulation of lipids in both liver and muscle of Iqgap2 -/-mice. A truncated TCA cycle impacts the overall function of the cycle resulting in incomplete oxidation of substrates (DeBerardinis et al. 2008) . Hepatic accumulation of lipids also leads to TCA overload, incomplete/excessive oxidation of fatty acids and eventual accumulation of ROS linked to mitochondrial dysfunction (Garcia-Ruiz et al. 2013) . We observed increases in apoA-II and peroxisomal alpha-methyl coA racemase (AMACR) in Iqgap2 -/-livers during fasting. The apolipoprotein apoA-II is a major protein constituent of HDL cholesterol and is known to modulate cellular cholesterol efflux (Tailleux et al. 2002) . Over expression of mouse apoA-II has been shown to induce fatty lesions even on a chow diet through alterations in oxidized lipoprotein metabolism and induction of inflammation (Zhong et al. 1994) . AMACR is a peroxisomal and mitochondrial enzyme involved in the b-oxidation of branched fatty acids. AMACR has been recently identified as a cancer biomarker (Lloyd et al. 2013 ) with a mechanism involving FXR and PPAR activity and expression of cyclooxygenase-2 (COX-2). Peroxisomes play a specialized role in the metabolism of VLCFAs, long-chain dicarboxylic acids, branched-chain fatty acids, eicosanoids, and bile acids which both generates and scavenges lipid peroxides involved in the oxygen radical homeostasis (Dansen and Wirtz 2001) . Thus increases in apoA-II and AMACR seen in Iqgap2 -/-mice may suggest oxidative degradation of lipids sources for lipid peroxides which can severely impact mitochondrial function. Obesity combined with oxidized lipid species compromises mitochondrial function through nonspecific modification of proteins, lipids, and nucleic acids (Gutierrez et al. 2006 ). Impaired mitochondrial function may be a primary cause for metabolic inflexibility (van de Weijer et al. 2013; Galgani et al. 2008) . Indirect calorimetry results from our study clearly indicated that Iqgap2 -/-mice were metabolically inflexible during the fast to refed transition. Iqgap2 -/-mice were unable to switch from fat to carbohydrate oxidation as seen from the lower RER during the refed period.
The results presented so far highlight that IQGAP2 deficiency presented with metabolic dysregulations that underlie the pathology associated with the development of diabetes. Most of these metabolic alterations share commonalties with metabolic reprogramming during carcinogenesis. Chronic hyperinsulinemia results and leads to a chain of metabolic responses, including changes in insulin and IGF binding proteins which play a key role in cell growth and differentiation (Pisani 2008) . Also obesity is considered a major risk factor for cancer (Fair and Montgomery 2009) . Alterations in glycolytic flux, truncated TCA cycle, shunting of glucose-derived carbon for macromolecular synthesis, increased de novo lipogenesis are hallmarks for cancer metabolism (DeBerardinis et al. 2008) . We discuss the IQGAP2 deficient proteomic and metabolomic changes in the following section that might predispose to the development of HCC in light of hyperinsulinemia and obesity seen in Iqgap2 -/-mice.
IQGAP2 deficiency and cancer
M2-PK is characteristic isoform of pyruvate kinase expressed in highly proliferative cells, and, a shift in the isoenzyme composition takes place such that the tissue specific isoenzyme, or L-PK in the liver, disappears and M2-PK is expressed during tumor formation (Mazurek et al. 2002) . Interestingly, we detected increased levels of both regular (R/L) and M2-PK isoforms of pyruvate kinase in Iqgap2 -/-mice (see Supplemental Notes and Supplemental Figure S8 , Supplemental Table S4) in our study. We also detected increased levels of critical enzymes from glycine cleavage system (H and P proteins) in Iqgap2 -/-livers. The observation was reflected by significantly altered plasma fast and fast/refed ratios for serine (increased) and glycine (decreased) that suggests glycine consumption, characteristic feature for both cancer and rapidly proliferating non-cancer cells for nucleotide synthesis (Jain et al. 2012) . Also 3-phosphoglycerate a critical intermediate at the branch point of glycolysis and serine biosynthesis was found to be also significantly increased in Iqgap2 -/-livers during fasting. We also detected increased levels of glycine methyl transferase and 10-formyltetrahydrofolate dehydrogenase which are enzymes involved in methyl group and folate metabolism important for nucleotide biosynthesis. The proteomics results suggesting metabolism favoring nucleotide synthesis in 18 h fast Iqgap2 -/-livers was supported by the observation of significantly increased pentose intermediates critical for de novo purine biosynthesis. Thus these results strongly presage a hepatic environment conducive for cell proliferation with IQGAP2 deficiency.
Increased levels of critical redox-related ROS quenching enzymes (thioredoxins), enzymes from oxidative lipid metabolism (discussed earlier), antioxidant enzymes from glutathione metabolism (Table 1) and decreased antioxidant metabolites observed in our study is suggestive of deteriorating mitochondrial function. Studies have previously shown that adenylate kinase 2 (AK2), isoform of adenylate kinase present in the mitochondrial inter membrane space, can meet cellular ATP demands under conditions of diminished oxidative phosphorylation (Burkart et al. 2011) . Also, oxidative stress can lead to elevated levels of mitochondrial transcription factors or other proteins of oxidative-phosphorylation (Gong et al. 1998; Li et al. 2002) . We found that Iqgap2 -/-mice demonstrated more than 3-fold increases in AK2 and complex V (ATP synthase a-subunit) during the 18 h fast; mitochondrial proteins from OXPHOS machinery namely cytochromes (b5, complex III), were increased by 2.5-fold during the refed experiments, suggesting an increased cellular demand for ATP. Re-direction of glycolytic carbons towards lipogenesis, and increased pentose flux towards biosynthesis with IQGAP2 deficiency drives a Warburg-like metabolism and aides cell proliferation. Warburg effect is characterized by aerobic glycolysis through increased pentose cycle activity, and increased anaplerosis in the mitochondria. These features enable cancer cells to increase macromolecules synthesis and proliferation. Thus persistence of futile substrate cycling can make Iqgap2 -/-livers susceptible to 'hypoxia' a late occurring cellular event known to promote neoplastic transformation (Heiden et al. 2009 ).
Conclusion
Our study highlights the importance of scaffolding proteins like IQGAP2 in cellular intermediary metabolism. Using an integrative approach we were able to demonstrate that IQGAP2 deficiency in liver leads to altered balance of flux (homeostasis) in glucose and protein metabolism that predispose to the development of hepatocellular carcinoma and diabetes. Whilst metabolomics and proteomics measurements in our study, clearly demonstrate that Iqgap2 -/-mice exhibit significant changes in homeostatic states compared with controls; how exactly these changes come about warrants further studies with precise assessments of metabolite and protein turnover rates using specific tracers.
Protein scaffolds are crucial for retaining the specificity of cellular signaling through temporal control and spatial fidelity of various proteins involved (Scott and Newton 2012) . IQGAP2 is a multi-domain, scaffolding protein, a PKA substrate and plays a critical role in actin dynamics and cytoskeletal regulation (Shannon 2012) . Previous evidence supports the notion that the cytoskeleton is a 'metabolic sensor' which integrates and regulates activity of metabolic enzymes through enzyme-cytoskeleton interactions (Sipe et al. 2010; Ingerson-Mahar et al. 2010; Barry and Gitai 2011; An et al. 2010) . Our studies have demonstrated that IQGAP2 deficiency resulted in alterations in metabolic networks that compromise cellular homeostasis. It can be speculated that dysregulated cytoskeletal dynamics combined with aberrant spatial fidelity of PKA signaling contributed to IQGAP2 deficient metabolic phenotype. For example the glycolytic enzyme fructose bisphosphate aldolase which was observed to be increased by 2.6-fold in Iqgap2 -/-livers in our study, has been shown to bind F-actin (Wang et al. 1996 (Wang et al. , 1997 which is critical for localizing and proper compartmentalization of aldolase. On these lines it would be interesting to investigate whether the changes in glycolysis observed in Iqgap2 -/-mice are due to altered reorganization of cytoskeleton. Further in-depth signaling and protein-protein interaction studies would confirm the direct involvement of IQGAP2. The dual metabolic/tumorigenic function together with its scaffolding function makes IQGAP2 a potential protein linking etiology of carcinogenesis and diabetes. Understanding of the specific action of IQGAP2 on metabolic pathways may provide rational therapeutic targets for the treatment and prevention of cancer and diabetes.
